Hudson Bay Capital Management
CRBP icon

Hudson Bay Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Hudson Bay Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$278K Buy
29,578
+12,489
+73% +$105K ﹤0.01% 1048
2025
Q4 		$139K Buy
+17,089
New +$211K ﹤0.01% 995
2024
Q3 		– Sell
-43,000
Closed -$1.95M – 907
2024
Q2 		$1.95M Hold
43,000
– – 0.01% 530
2024
Q1 		$1.69M Buy
+43,000
New +$1.06M 0.01% 483

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hudson Bay Capital Management's CRBP Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Corbus Pharmaceuticals (CRBP) stake by 73% in Q1 2026, buying an estimated $105K and bringing the position to 29,578 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Hudson Bay Capital Management first reported a position in CRBP in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.95M in Q2 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Hudson Bay Capital Management held 29,578 shares of Corbus Pharmaceuticals worth $278K as of Q1 2026.
  • Hudson Bay Capital Management bought 12,489 Corbus Pharmaceuticals shares in Q1 2026, an estimated $105K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1048 holding.
  • Hudson Bay Capital Management first reported a position in Corbus Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Hudson Bay Capital Management's Corbus Pharmaceuticals position peaked at $1.95M in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.